Recent progress in understanding 2019 novel coronavirus (SARS-CoV-2) associated with human respiratory disease: detection, mechanisms and treatment
- 29 March 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 55 (5), 105950
- https://doi.org/10.1016/j.ijantimicag.2020.105950
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitorNature Communications, 2014
- TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike ProteinJournal of Virology, 2014
- Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaquesNature Medicine, 2013
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirinScientific Reports, 2013
- A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2Antiviral Research, 2012
- Activation and maturation of SARS-CoV main proteaseProtein & Cell, 2011
- Upregulation of the Chemokine (C-C Motif) Ligand 2 via a Severe Acute Respiratory Syndrome Coronavirus Spike-ACE2 Signaling PathwayJournal of Virology, 2010
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to PathogenesisJournal of Virology, 2005
- Costimulation of Fibroblast Collagen and Transforming Growth Factor β1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific ReceptorsOnline Journal of Public Health Informatics, 1996